市場調査レポート

無針薬剤注射システムと安全注射器の世界市場

Needle-Free Drug Injection Systems and Safety Syringes

発行 Global Industry Analysts, Inc. 商品コード 248890
出版日 ページ情報 英文 504 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
無針薬剤注射システムと安全注射器の世界市場 Needle-Free Drug Injection Systems and Safety Syringes
出版日: 2012年07月01日 ページ情報: 英文 504 Pages
概要

当レポートでは、無針薬剤注射システムと安全注射器の世界市場を取り上げ、米国、カナダ、日本、欧州、アジア太平洋、およびその他の地域など、地域ごとの個別分析を行うとともに、過去の実績/推定および将来の予測を提供し、主要企業およびニッチ企業93社のプロフィールをまとめるなど、概略以下の構成でお届けします。

第1章 イントロダクション、調査方法、製品定義

  • 調査の信頼性とレポートの制約
  • 免責事項
  • データの解釈とレポートのレベル
    • 定量技法および分析法
  • 製品の定義と調査範囲
    • 安全注射器
    • 無針注射

第2章 エグゼクティブサマリー

  • 産業概要
    • 市場概要
    • 現在および将来の分析
    • 針刺し損傷:医療環境における脅威
    • 進化する薬剤投与システム
    • 安全注射器におけるユーザーの選択を決定づける要素
    • 安全および事前充填注射の採用を可能にする要素
    • 無針注射システムの主要な優位点
    • 立法:技術向上および重要の基礎
    • 投与システムのさらなる進展を目指した現在の研究が市場成長を後押し
    • 複数の薬剤送達代替手段を提供することが見込まれる将来の市場
    • 無針注射システム市場
    • 無針システムに対する需要が増加中
    • 無針注射に向けた動向
    • 競争的後発医薬品による差別化を通じた特許寿命の延長
    • 安全性と効率性:主たる原動力
    • 患者の関与
    • 将来における無針化の可能性は低い
    • 規制:無針市場にとってのカンフル剤
    • 安全注射器市場
    • 事前充填安全注射器に対する需要は北方に向かう
    • 事前充填注射器:すべてのステークホルダーに恩恵をもたらす
    • 安全注射器のさらなる発展を切望する市場
    • インスリン投与:新たな投与システムにとっての急成長市場
    • 競合情勢
    • その他の主な統計
    • 堅調な即時充填可能セグメント
  • 製品概要
    • イントロダクション
    • 歴史的背景
    • メカニズム
    • 安全注射器
    • 事前充填注射器
    • 経口ワクチン
    • 鼻腔用スプレー、坐薬、ならびに点眼および点鼻薬
    • 吸入具
    • 経皮
    • 生産に使われる素材
    • 無針注射システムの設計
    • 生産プロセス
    • 各部品の生産
    • 組立とラベル付け
    • パッケージング
    • 品質管理
    • 安全な医療機器
    • 自動注射器およびペン型注射器
    • 人間にとっての利点
    • 幅広い患者の受け入れとコンプライアンス
    • 強化された安全性
    • 効果の向上
    • 素早い注射
    • 動物に無針注射器を用いることの利点
    • 疾病伝播の削減
    • 免疫の向上
    • 牛肉品質の向上
    • 従業員の安全性
    • 液体および固形物の無針投与
  • 製品の発表
  • 業界における最近の動き
  • 主要な国際企業
    • First Principals, Inc.(米国)
    • Cambridge Consultants Ltd.(英国)
    • Antares Pharma, Inc.(米国)
    • Bard Biopsy Systems(米国)
    • Baxter International, Inc.(米国)
    • Baxter BioPharma Solutions(米国)
    • Bector, Dickinson(米国)
    • BD Medical
    • Bioject Medical Technologies, Inc.(米国)
    • Covidien Plc(アイルランド)
    • Crossject Ltd.(フランス)
    • D'Antonio Consultants International, Inc.(米国)
    • Glide Pharmaceutical Technologies Ltd.(英国)
    • Incline Therapeutics, Inc.(米国)
    • INJEX Pharma GmbH(ドイツ)
    • Medical International Technologies (Mit Canada), Inc.(カナダ)
    • National Medical Products, Inc.(米国)
    • PenJet Corporation
    • PowderJect Pharmaceuticals Plc(英国)
    • Retractable Technologies, Inc.(米国)
    • Safety Syringes, Inc.(米国)
    • Smiths Group(英国)
    • Smiths Medical(米国)
    • テルモ(日本)
    • Unilife Medical Solutions Ltd.(米国)
    • Valeritas(米国)
    • Ypsomed Holding AG(ドイツ)
    • Zogenix, Inc.(米国)
  • 世界市場の展望

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
    • フランス
    • ドイツ
    • イタリア
    • 英国
    • スペイン
    • ロシア
    • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合情勢

目次
Product Code: MCP-6962

This report analyzes the worldwide markets for Needle-Free Drug Injection Systems and Safety Syringes in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 93 companies including many key and niche players such as First Principals, Inc., Cambridge Consultants Ltd., Antares Pharma, Inc., Bard Biopsy Systems, Baxter International, Inc., Baxter BioPharma Solutions, Bector, Dickinson, BD Medical, Bioject Medical Technologies, Inc., Covidien Plc, Crossject Ltd., D'Antonio Consultants International, Inc., Glide Pharmaceutical Technologies Ltd., Incline Therapeutics, Inc., INJEX Pharma GmbH, Medical International Technologies (Mit Canada), Inc., National Medical Products, Inc., PenJet Corporation, PowderJect Pharmaceuticals Plc, Retractable Technologies, Inc., Safety Syringes, Inc., Smiths Group, Smiths Medical, Terumo Corporation, Unilife Medical Solutions Ltd., Valeritas, Ypsomed Holding AG, and Zogenix, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study
    • Safety Syringes
    • Needle-Free Injections

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • A Prelude
  • Market Overview
  • Current and Future Analysis
  • Needlestick Injuries - A Menace in Healthcare Environment
  • Evolving Drug Delivery Systems
  • Factors Determining User Choice in Safety Syringes
  • Factors Enabling Espousal of Safety and Pre-filled Injections
  • Major Advantages of Needle-Free Injection Systems
  • Legislations - The Base for Technology Improvements and Demand
  • Ongoing Research to Further Advance Delivery Systems, Fuel Market Growth
  • Future Market to Offer Multiple Drug Delivery Alternatives
  • Needle-Free Injection Systems Market
  • Demand for Needle-Free Systems Gathers Pace
  • Trends toward Needle-Free Injections
  • Extending Patent Life through Differentiation from Competitive Generics
  • Safety and Efficacy - Amongst the Prime Motivating Factors
  • Patient Involvement
  • Needle-Free Future Unlikely
  • Regulations - A Shot on the Arm for Needle-free Market
  • Safety Syringes Market
  • Demand for Pre-filled Safety Syringes North-Bound
  • Pre-filled Syringes - Benefiting All Stakeholders
  • Markets Crave for Further Advancements in Safety Syringes
  • Insulin Delivery - A Burgeoning Market for Novel Delivery Systems
  • Competitive Landscape
    • Table 1: Leading Suppliers of Safety Syringes Worldwide (2011E): Percentage Breakdown of Sales for Becton, Dickinson and Company, Covidien, Terumo, Retractable and Others (includes corresponding Graph/Chart)
  • Other Key Statistics
    • Table 2: Leading Pharmaceutical Companies in the Pre-Filled Vaccine Syringes Market (2011): Percentage Breakdown of Revenues for GSK, Sanofi, Novartis and Others (includes corresponding Graph/Chart)
    • Table 3: Leading Pharmaceutical Companies in the Pre-Filled Hematology Syringes Market (2011): Percentage Breakdown of Revenues for Roche, Amgen and Others (includes corresponding Graph/Chart)
    • Table 4: Leading Pharmaceutical Companies in the Pre-Filled Anti-Coagulant Syringes Market (2011): Percentage Breakdown of Revenues for Sanofi, GSK and Others (includes corresponding Graph/Chart)
  • Ready-to-Fill Segment Goes Strong
    • Table 5: Global Ready-to-Fill Syringe Consumption: 2007-2011 (In Billion Units) (includes corresponding Graph/Chart)
    • Table 6: Leading Pharmaceutical Companies by Pre-filled Syringe Consumption (2011): Percentage Breakdown of Value Consumption for Sanofi, GSK, Novartis, Pfizer, Roche and Others (includes corresponding Graph/Chart)
    • Table 7: World Sales of Drugs in Pre-filled Syringes by Therapeutic Class (2011): Percentage Breakdown of Revenues for Vaccines, Hematology, Multiple Sclerosis, Anti-inflammatory, Anticoagulants and Others (includes corresponding Graph/Chart)

2. PRODUCT OVERVIEW

  • Introduction
  • Historical Background
  • Mechanism
  • Safety Syringe
  • Pre-Filled Syringe
  • Oral Vaccines
  • Nasal Sprays, Suppositories and Eye and Nose Drops
  • Inhalers
  • Transdermal
    • Injected Fine Mist or Powder
    • Jet Injectors
    • Iontophoretic Transdermal
    • Patches
    • Implants
    • Microneedles
  • Material Used for Production
  • Designing of Needle-free Injection Systems
  • The Production Process
  • Manufacturing the Pieces
  • Assembling and Labeling
  • Packaging
  • Quality Control
  • Safe Medical Devices
  • Auto-Injectors and Pen Injector
  • Benefits for Human
  • Greater Patient Acceptance and Compliance
  • Enhanced Safety
  • Improved Effectiveness
  • Swift Injection Time
  • Advantages of Using Needle-Free Injectors in Animals
  • Disease Transmission Reduction
  • Immunology Improvement
  • Improvement in Beef Quality
  • Employee Safety
  • Needle-free Delivery of Liquids and Solids

3. PRODUCT INTRODUCTIONS

  • Revolutions Medical Launches New Improved Website
  • MedPro Safety Products Launches Pre-filled Safety Syringe
  • MedPro Safety Products Launches Passive Hypodermic Safety Syringe
  • Greiner Bio-One and MedPro Safety Products Launch PREMIUM Safety Needle System Tube-Touch
  • MIT Introduces MED-JET® Products in the Russian Market
  • Revolutions Medical Develops Pre-filled Auto Retractable Vacuum Safety Syringes
  • ALK-Abello Unveils Jext - A New Adrenaline Auto-Injector
  • Fred Meyer Stores Offers Bioject Medical Technologies' Biojector® 2000
  • Revolutions Medical Introduces New Automatic Retractable Safety Syringe Designs
  • Revolutions Medical Unveils 3ml RevVac Safety Syringe
  • SCHOTT Pharmaceutical Packaging Develops InJentle™
  • PharmaJet Develops Needle-Free Jet Injection Technology
  • Smiths Medical Launches Medfusion® 4000 Syringe Infusion Pump
  • Teva Pharmaceutical Industries Rolls Out New Tjet™ Needle-Free Injector System
  • Occupational and Medical Innovations Rolls Out Auto-Retractable Safety Syringe
  • Pharmastandard to Launch Ypsomed's Ypsopen in Russia

4. RECENT INDUSTRY ACTIVITY

  • Insvet and AcuShot™ Ink Distribution Agreement
  • Antares Pharma Receives US Patent for Vibex™ Technology
  • Paketeria Acquires INJEX Pharma
  • Unilife Commences Sale of Unifill Ready-to-fill Syringes to Multinational Pharmaceutical Company
  • Zogenix and DURECT Sign Development and License Agreement
  • Clinigen Pharma and Zogenix Sign Collaborative Agreement
  • Bioject Medical Technologies to Supply Intradermal Pen
  • Revolutions Medical to Manufacture 5 million RevVac 1ml Fixed Needle Safety Syringe Every Month
  • Revolutions Medical Receives Clearance from the DLA for the RevVac Safety Syringe
  • Revolutions Medical Files Provisional Patent Application for Vacuum Technology-based Pre-Filled Safety Syringes
  • Medical International Technology Gains Chinese SFDA Certification for MED-JET® Products
  • Revolutions Medical and CeifiT Ink Marketing and Distribution Agreement
  • Revolutions Medical and DS WorldMed Ink Marketing and Distribution Agreement
  • Revolutions Medical and Wuxi Yushou Medical Appliance Ink Definitive Manufacturing Agreement
  • INJEX Pharma and Al Shamali Group Ink an Exclusive Distributor Contract
  • INJEX Pharma Inks Exclusive Sales and Marketing Agreement with GenTech Laboratories for INJEX Needle-Free Syringes
  • Unilife Bags Supply Contract for Unitract Safety Syringes from Premier Purchasing Partners
  • US FDA Grants Two 510(k) Marketing Clearances for PharmaJet's IM/SC Injection Technology
  • Zogenix Ends Co-Promotion Agreement with Astellas Pharma for the SUMAVEL DosePro
  • Kroger Include PharmaJet Needle-Free Injection Systems in Flu-Shot Campaign
  • Valeritas' V-Go™ Disposable Insulin Delivery Medical Device Obtains CE Mark Approval
  • Revolutions Medical Receives Patent for Marketing RevVac Safety Syringe in the Chinese Market
  • Zogenix and Desitin Obtain Marketing Approval for SUMAVEL DosePro
  • Smiths Medical to Establish Subsidiary in India
  • Unilife Commences Unifill Pre-filled Syringe Production
  • PharmaJet Secures FDA Clearance for Intradermal Needle-Free Injection Device
  • Cadence Enters into Agreement for Acquiring Incline Therapeutics
  • PharmaJet Signs Collaboration Agreement with USAMRIID
  • Revolution Medical and Santa Monica Pharmaceutica Enter into Strategic Partnership
  • Standard Chem and Pharm Enters into Distribution Agreement with Unilife
  • Bioject Medical Technologies and MPI Research Enter into Alliance
  • Revolutions Medical and MIG Sign Manufacturing Agreement
  • Protectus Medical Devices Inks Agreement with Moll
  • Unilife Starts Selling Unitract® 1ml Syringes
  • Inviragen and PharmaJet Obtain NIAID Contract for Developing Needle-Free Dengue Vaccine
  • Safety Syringes Selects Polycarbonate Resin of Bayer MaterialScience
  • Incline Therapeutics and ALZA Enter into Agreement
  • Desitin Pharmaceuticals and Zogenix Obtain Marketing Authorization for SUMAVEL® DosePro™ from Danish Medicines Agency
  • Antares Pharma Announces Advancements in Vibex™ Auto-Injectors
  • TOLMAR Holding Acquires QLT USA
  • SquareOne Medical Completes Reverse Merger into E-18
  • West Pharmaceutical Services Takes Over Assets of Plastef Investissements
  • Revolutions Medical Obtains FDA Approval for Marketing Rev Vac Safety Syringe
  • Bioject Medical Technologies and Ferring Pharmaceuticals Extend Supply Agreement
  • Med-Pharmex and AcuShotTM Ink Exclusive Distribution Agreement
  • Revolutions Medical and Libra International Ink Distribution Agreement
  • Cardinal Health and OMI Ink Exclusive Distribution Agreement
  • Astellas Pharma and Zogenix Ink Agreement to Co-Promote Sumavel DosePro
  • Unilife and Sanofi Winthrop Industrie Ink Industrialization Agreement
  • Bioject Medical Technologies Receives FDA 510(k) Clearance for ZetajetTM
  • PharmaJet Collaborates with PATH
  • Lipoxen and Glide Pharma Ink Agreement
  • Ypsomed Holding and Gamma Medica Enter into Distribution Agreement
  • Zogenix Receives FDA Approval for SUMAVEL® DoseProTM

5. FOCUS ON SELECT KEY PLAYERS

  • First Principals, Inc. (US)
  • Cambridge Consultants Ltd. (UK)
  • Antares Pharma, Inc. (US)
  • Bard Biopsy Systems (US)
  • Baxter International, Inc. (US)
  • Baxter BioPharma Solutions (US)
  • Bector, Dickinson (US)
  • BD Medical
  • Bioject Medical Technologies, Inc. (US)
  • Covidien Plc (Ireland)
  • Crossject Ltd. (France)
  • D'Antonio Consultants International, Inc. (US)
  • Glide Pharmaceutical Technologies Ltd. (UK)
  • Incline Therapeutics, Inc. (US)
  • INJEX Pharma GmbH (Germany)
  • Medical International Technologies (Mit Canada), Inc. (Canada)
  • National Medical Products, Inc. (US)
  • PenJet Corporation
  • PowderJect Pharmaceuticals Plc (UK)
  • Retractable Technologies, Inc. (US)
  • Safety Syringes, Inc. (US)
  • Smiths Group (UK)
  • Smiths Medical (US)
  • Terumo Corporation (Japan)
  • Unilife Medical Solutions Ltd. (US)
  • Valeritas (US)
  • Ypsomed Holding AG (Germany)
  • Zogenix, Inc. (US)

6. GLOBAL MARKET PERSPECTIVE

    • Table 8: World Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 9: World Historic Review for Needle-Free Drug Injection Systems and Safety Syringes by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 10: World 15-Year Perspective for Needle-Free Drug Injection Systems and Safety Syringes by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2004, 2011 and 2018 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current and Future Analysis
    • The Torch Bearers
    • Leading Players Operating in the Largest Individual Market
    • Product Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 11: US Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 12: US Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launch
    • Medical International Technologies (Mit Canada), Inc. - A Leading Canadian Player
  • B. Market Analytics
    • Table 13: Canadian Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 14: Canadian Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current and Future Analysis
    • Terumo Corporation - A Leading Japanese Player
  • B. Market Analytics
    • Table 15: Japanese Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 16: Japanese Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • Region-Wide Laws on Safety Syringes on the Cards
  • B. Market Analytics
    • Table 17: European Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 18: European Historic Review for Needle-Free Drug Injection Systems and Safety Syringes by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)
    • Table 19: European 15-Year Perspective for Needle-Free Drug Injection Systems and Safety Syringes by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2004, 2011 and 2018 (includes corresponding Graph/Chart)

4a. FRANCE

  • A. Market Analysis
    • Current and Future Analysis
    • Strategic Corporate Developments
    • Crossject Ltd. - A French Player
  • B. Market Analytics
    • Table 20: French Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 21: French Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launch
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 22: German Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 23: German Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 24: Italian Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 25: Italian Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current and Future Analysis
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 26: UK Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 27: UK Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4e. SPAIN

  • A. Market Analysis
    • Current and Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 28: Spanish Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 29: Spanish Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4f. RUSSIA

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launches
  • B. Market Analytics
    • Table 30: Russian Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 31: Russian Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Current and Future Analysis
    • Product Launch
    • Strategic Corporate Developments
    • Covidien Plc - An Irish Player
  • B. Market Analytics
    • Table 32: Rest of Europe Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 33: Rest of Europe Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current and Future Analysis
    • Demand for Safety Syringes in Asia Yet to Take Off
    • Safety Syringe Market in India Sets Off
    • Product Launch
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 34: Asia-Pacific Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 35: Asia-Pacific Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • A. Market Analysis
    • Current and Future Analysis
    • Strategic Corporate Developments
  • B. Market Analytics
    • Table 36: Rest of World Recent Past, Current and Future Analysis for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart)
    • Table 37: Rest of World Historic Review for Needle-Free Drug Injection Systems and Safety Syringes Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top